Trusted biotech investor, advisor Burrill accused of fraud
This article was originally published in Scrip
Executive Summary
Trusted life science investor, lender and advisor Steven Burrill's reputation is on the line in a lawsuit filed by a former employee who claims that Mr Burrill and his companies took more than $19m from a venture capital fund that they managed.
You may also be interested in...
Once-Trusted Investment Advisor Burrill Faces Criminal Fraud Charges
A federal grand jury indicted Steven Burrill and an associate on charges of fraud and tax evasion regarding investment funds run by the San Francisco-based life science advisor, who settled a related SEC claim in 2016. If convicted, he could spend decades in prison and pay millions in fines.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.
Sage’s Dalzanemdor Prospects In Doubt After First Mid-Stage Readout
Dalzanemdor (SAGE-718) showed no difference from placebo in a Phase II Parkinson’s disease study, raising concerns about readouts later this year in Huntington’s and Alzheimer’s diseases.